| Literature DB >> 35774452 |
Qian Tao1, Qian Wu1, Zhaohuan Zhang1, Jing Liu1, Cuifang Tian1, Zhenhua Huang1, Pradeep K Malakar1, Yingjie Pan1,2,3, Yong Zhao1,2,3.
Abstract
Antimicrobial-resistant (AMR) foodborne bacteria causing bacterial infections pose a serious threat to human health. In addition, the ability of some of these bacteria to form biofilms increases the threat level as treatment options may become compromised. The extent of antibiotic resistance and biofilm formation among foodborne pathogens remain uncertain globally due to the lack of systematic reviews. We performed a meta-analysis on the global prevalence of foodborne pathogens exhibiting antibiotic resistance and biofilm formation using the methodology of a Cochrane review by accessing data from the China National Knowledge Infrastructure (CNKI), PubMed, and Web of Science databases between 2010 and 2020. A random effects model of dichotomous variables consisting of antibiotic class, sample source, and foodborne pathogens was completed using data from 332 studies in 36 countries. The results indicated AMR foodborne pathogens has become a worrisome global issue. The prevalence of AMR foodborne pathogens in food samples was greater than 10% and these foodborne pathogens were most resistant to β-lactamase antibiotics with Bacillus cereus being most resistant (94%). The prevalence of AMR foodborne pathogens in human clinical specimens was greater than 19%, and the resistance of these pathogens to the antibiotic class used in this research was high. Independently, the overall biofilm formation rate of foodborne pathogenic bacteria was 90% (95% CI, 68%-96%) and a direct linear relationship between biofilm formation ability and antibiotic resistance was not established. Future investigations should document both AMR and biofilm formation of the foodborne pathogen isolated in samples. The additional information could lead to alternative strategies to reduce the burden cause by AMR foodborne pathogens.Entities:
Keywords: antimicrobial resistance; biofilm; foodborne pathogens; global prevalence; meta-analysis
Year: 2022 PMID: 35774452 PMCID: PMC9239547 DOI: 10.3389/fmicb.2022.906490
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
Figure 1Study selection.
Figure 2Geographical distribution of reported resistance of the pathogens isolated from food or humans.
Included studies characteristics.
| Study characteristics | Human studies ( | Food studies ( |
|---|---|---|
|
| ||
| Africa | 2 (2%) | 22 (9%) |
| Asia | 99 (95%) | 188 (77%) |
| Europea | 1 (1%) | 6 (2%) |
| North America | — | 10 (4%) |
| Oceania | — | 1 (1%) |
| South America | 2 (2%) | 6 (2%) |
|
| ||
| 2000–2010 | 21 (20%) | 51 (21%) |
| 2011–2015 | 48 (46%) | 108 (44%) |
| 2016–2020 | 35 (34%) | 74 (30%) |
|
| ||
| Disk diffusion | 46 (44%) | 156 (64%) |
| MIC | 44 (42%) | 61 (25%) |
| Vitek | 10 (10%) | 10 (4%) |
| Others | — | 4 (2%) |
| Not reported | 4 (4%) | 2 (1%) |
|
| ||
| CLSI | 85 (82%) | 199 (82%) |
| EUCAST | 2 (2%) | 1 (1%) |
| NCCLS | 6 (6%) | 13 (5%) |
| Others | 1 (1%) | 6 (2%) |
| Not reported | 10 (10%) | 14 (6%) |
|
| ||
|
| 1 (1%) | 8 (3%) |
|
| 11 (10%) | 26 (11%) |
|
| 1 (1%) | 18 (7%) |
|
| 50 (48%) | 79 (32%) |
|
| 36 (35%) | 49 (20%) |
|
| 5 (5%) | 53 (22%) |
|
| ||
| Aquatic products | — | 78 (32%) |
| Meat | — | 50 (20%) |
| Milk and dairy products | — | 12 (5%) |
| RET-food | — | 13 (5%) |
| Others | — | 80 (33%) |
| Foodborne diarrhea patients | 93 (89%) | |
| Food poisoning samples | 10 (10%) | |
| Food handlers | 1 (1%) | |
|
| — | 11 (5%) |
Pooled prevalence of antibiotic resistance from meta-analysis of food studies and human studies, by antibiotic category.
| Food studies | Human studies | |||
|---|---|---|---|---|
| Articles ( | Prevalence % (95% CI) | Articles ( | Prevalence % (95% CI) | |
|
| ||||
|
| ||||
| Aminoglycosides | 11 | 32 (19–46) | 8 | 25 (19–31) |
| β-Lactams | 19 | 56 (45–67) | 10 | 61 (51–70) |
| Chloramphenicol | 8 | 25 (15–34) | 6 | 19 (8–30) |
| Fluoroquinolones | 12 | 37 (22–52) | 8 | 38 (18–58) |
| Sulfonamides | 19 | 48 (30–65) | 9 | 39 (26–52) |
| Tetracyclines | 21 | 54 (41–57) | 9 | 49 (43–55) |
|
| ||||
| Aminoglycosides | 31 | 39 (31–47) | 17 | 44 (27–61) |
| β-Lactams | 42 | 47 (38–55) | 33 | 56 (47–66) |
| Chloramphenicol | 18 | 32 (21–43) | 18 | 33 (24–42) |
| Fluoroquinolones | 42 | 44 (30–59) | 24 | 50 (40–60) |
| Sulfonamides | 34 | 42 (29–54) | 26 | 43 (32–54) |
| Tetracyclines | 30 | 56 (47–64) | 27 | 45 (35–54) |
|
| ||||
| Aminoglycosides | 39 | 45 (36–53) | 14 | 22 (11–33) |
| β-Lactams | 77 | 77 (71–83) | 37 | 76 (69–82) |
| Fluoroquinolones | 7 | 13 (7–19) | 8 | 19 (−7–44) |
| Sulfonamides | 36 | 14 (10–18) | 11 | 25 (−1–52) |
| Tetracyclines | 22 | 14 (11–17) | 6 | 2 (0–4) |
|
| ||||
|
| ||||
| β-Lactams | 6 | 94 (91–98) | 1 | 81 (75–86) |
| Sulfonamides | 3 | 32 (6–58) | 1 | 66 (60–73) |
|
| ||||
| Aminoglycosides | 6 | 21 (8–35) | — | — |
| β-Lactams | 13 | 45 (27–63) | 1 | 54 (38–70) |
| Chloramphenicol | 8 | 30 (11–49) | - | - |
| Fluoroquinolones | 9 | 11 (6–16) | 1 | 62 (47–78) |
| Sulfonamides | 6 | 11 (3–19) | — | — |
| Tetracyclines | 13 | 22 (15–30) | 1 | 30 (15–44) |
|
| ||||
| Aminoglycosides | 33 | 30 (24–36) | 2 | 30 (−12–73) |
| β-Lactams | 45 | 78 (73–82) | 3 | 68 (32–102) |
| Chloramphenicol | 17 | 16 (12–19) | — | — |
| Fluoroquinolones | 27 | 23 (19–28) | 1 | 36 (8–65) |
| Sulfonamides | 19 | 31 (19–43) | 2 | 35 (5–66) |
| Tetracyclines | 43 | 41 (33–48) | 4 | 28 (4–52) |
Subgroup analysis of antibiotic resistance by food types.
| Aquatic products | Meat | Milk and dairy products | RTE-food | |||||
|---|---|---|---|---|---|---|---|---|
| Articles ( | Prevalence % (95% CI) | Articles ( | Prevalence % (95% CI) | Articles ( | Prevalence % (95% CI) | Articles ( | Prevalence % (95% CI) | |
| MDR | 9 | 42 (26–58) | 16 | 52 (40–63) | 4 | 43 (1–84) | 8 | 36 (21–51) |
| Aminoglycosides | 38 | 43 (34–51) | 36 | 29 (31–47) | 7 | 33 (14–51) | 6 | 35 (24–46) |
| β-Lactams | 65 | 73 (66–81) | 42 | 62 (52–70) | 9 | 61 (45–77) | 10 | 57 (34–83) |
| Chloramphenicol | — | — | 19 | 36 (21–51) | 4 | 21 (17–25) | 4 | 25 (16–34) |
| Fluoroquinolones | 11 | 13 (8–19) | 38 | 39 (25–53) | 5 | 30 (14–46) | 9 | 25 (16–34) |
| Sulfonamides | 34 | 14 (11–17) | 32 | 47 (31–63) | 7 | 62 (46–78) | 7 | 43 (10–76) |
| Tetracyclines | 21 | 22 (9–35) | 36 | 62 (54–70) | 9 | 28 (2–55) | 8 | 43 (24–63) |
Subgroup analysis of antibiotic resistance by study population.
| Diarrhea patients | Food poisoning samples | Food handlers | ||||
|---|---|---|---|---|---|---|
| Articles ( | Prevalence % (95% CI) | Articles ( | Prevalence % (95% CI) | Articles ( | Prevalence % (95% CI) | |
| Aminoglycosides | 34 | 32 (23–42) | 4 | 11 (0–21) | 1 | 23 (16–29) |
| β-Lactams | 78 | 65 (60–71) | 6 | 78 (62–95) | 1 | 65 (57–72) |
| Chloramphenicol | 23 | 29 (21–37) | — | — | 1 | 37 (30–45) |
| Fluoroquinolones | 41 | 42 (30–53) | 2 | 22 (6–39) | — | — |
| Sulfonamides | 46 | 39 (27–52) | 2 | 14 (2–26) | 1 | 47 (37–52) |
| Tetracyclines | 42 | 41 (33–48) | 5 | 21 (3–39) | 1 | 46 (37–52) |
Subgroup analysis of antibiotic resistance by region, time period and susceptibility test.
| Food studies | Human studies | |||
|---|---|---|---|---|
| Articles | Prevalence % (95% CI) | Articles | Prevalence % (95% CI) | |
|
| ||||
| Africa | 19 | 80 (75–86) | 2 | 92 (82–102) |
| Asia | 149 | 77 (73–81) | 93 | 82 (80–84) |
| Europe | 6 | 78 (68–89) | 1 | 48 (40–55) |
| North America | 10 | 76 (66–87) | — | — |
| Oceania | 1 | 85 (74–95) | — | — |
| South America | 6 | 97 (95–99) | 2 | 90 (80–100) |
|
| ||||
| Before 2010 | 40 | 75 (65–85) | 19 | 80 (75–84) |
| 2011–2015 | 75 | 72 (66–79) | 38 | 79 (75–83) |
| 2016–2020 | 51 | 80 (77–84) | 30 | 82 (78–86) |
|
| ||||
| Disk diffusion | 36 | 82 (79–85) | 112 | 78 (75–81) |
| MIC | 39 | 77 (72–82) | 47 | 69 (59–79) |
| Vitek | 9 | 88 (83–93) | 9 | 90 (85–95) |
Figure 3Forest plot of the meta-analysis of biofilm formation rate in foodborne pathogen retrieved from food samples. Study 1: Lapierre et al. (2020). Study 2: Lopez-Leon et al. (2016). Study 3: Rodríguez-Lázaro et al. (2018). Study 4: Beshiru and Igbinosa (2018). Study 5: Beshiru et al. (2018). Study 6: Chen and Xie (2019). Study 7: Maia et al. (2020). Study 8: Ou et al. (2020). Study 9: Puah et al. (2018). Study 10: Wang et al. (2020). Study 11: Kim et al. (2018).